Publication:
Cholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts.

dc.contributor.authorBerthier, Marcelo L
dc.contributor.authorDe-Torres, Irene
dc.contributor.authorParedes-Pacheco, Jose
dc.contributor.authorRoe-Vellve, Nuria
dc.contributor.authorThurnhofer-Hemsi, Karl
dc.contributor.authorTorres-Prioris, Maria J
dc.contributor.authorAlfaro, Francisco
dc.contributor.authorMoreno-Torres, Ignacio
dc.contributor.authorLopez-Barroso, Diana
dc.contributor.authorDavila, Guadalupe
dc.contributor.funderSpanish Ministry of Education, Culture and Sport
dc.contributor.funderSpanish Ministry of Economy and Competitiveness
dc.date.accessioned2023-01-25T09:48:13Z
dc.date.available2023-01-25T09:48:13Z
dc.date.issued2017-06-14
dc.description.abstractDonepezil (DP), a cognitive-enhancing drug targeting the cholinergic system, combined with massed sentence repetition training augmented and speeded up recovery of speech production deficits in patients with chronic conduction aphasia and extensive left hemisphere infarctions (Berthier et al., 2014). Nevertheless, a still unsettled question is whether such improvements correlate with restorative structural changes in gray matter and white matter pathways mediating speech production. In the present study, we used pharmacological magnetic resonance imaging to study treatment-induced brain changes in gray matter and white matter tracts in a right-handed male with chronic conduction aphasia and a right subcortical lesion (crossed aphasia). A single-patient, open-label multiple-baseline design incorporating two different treatments and two post-treatment evaluations was used. The patient received an initial dose of DP (5 mg/day) which was maintained during 4 weeks and then titrated up to 10 mg/day and administered alone (without aphasia therapy) during 8 weeks (Endpoint 1). Thereafter, the drug was combined with an audiovisual repetition-imitation therapy (Look-Listen-Repeat, LLR) during 3 months (Endpoint 2). Language evaluations, diffusion weighted imaging (DWI), and voxel-based morphometry (VBM) were performed at baseline and at both endpoints in JAM and once in 21 healthy control males. Treatment with DP alone and combined with LLR therapy induced marked improvement in aphasia and communication deficits as well as in selected measures of connected speech production, and phrase repetition. The obtained gains in speech production remained well-above baseline scores even 4 months after ending combined therapy. Longitudinal DWI showed structural plasticity in the right frontal aslant tract and direct segment of the arcuate fasciculus with both interventions. VBM revealed no structural changes in other white matter tracts nor in cortical areas linked by these tracts. In conclusion, cholinergic potentiation alone and combined with a model-based aphasia therapy improved language deficits by promoting structural plastic changes in right white matter tracts.
dc.description.versionSi
dc.identifier.citationBerthier ML, De-Torres I, Paredes-Pacheco J, Roé-Vellvé N, Thurnhofer-Hemsi K, Torres-Prioris MJ, et al. Cholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts. Front Hum Neurosci. 2017 Jun 14;11:304
dc.identifier.doi10.3389/fnhum.2017.00304
dc.identifier.issn1662-5161
dc.identifier.pmcPMC5470532
dc.identifier.pmid28659776
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470532/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fnhum.2017.00304/pdf
dc.identifier.urihttp://hdl.handle.net/10668/11356
dc.journal.titleFrontiers in human neuroscience
dc.journal.titleabbreviationFront Hum Neurosci
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Regional de Málaga
dc.page.number18
dc.provenanceRealizada la curación de contenido 27/03/2025
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.projectIDFPU14/04021
dc.relation.projectIDFPU15/06512
dc.relation.projectIDFJCI2014-22953
dc.relation.publisherversionhttps://doi.org/10.3389/fnhum.2017.00304
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAphasia therapy
dc.subjectCrossed aphasia
dc.subjectDonepezil
dc.subjectNeuroimaging
dc.subjectStructural plasticity
dc.subject.decsSustancia Blanca
dc.subject.decsAfasia de Conducción
dc.subject.decsColinérgicos
dc.subject.decsSustancia Gris
dc.subject.decsEncéfalo
dc.subject.meshAphasia, Conduction
dc.subject.meshSpeech
dc.subject.meshNootropic Agents
dc.subject.meshImitative Behavior
dc.subject.meshBrain
dc.titleCholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5470532.pdf
Size:
2.84 MB
Format:
Adobe Portable Document Format